Apremilast is a phosphodiesterase-4 (PDE4) inhibitor that modulates inflammatory pathways and is indicated for the treatment of conditions such as psoriatic arthritis, plaque psoriasis, and Behçet’s disease.… Read more
















































Apremilast is a phosphodiesterase-4 (PDE4) inhibitor that modulates inflammatory pathways and is indicated for the treatment of conditions such as psoriatic arthritis, plaque psoriasis, and Behçet’s disease. In pharmaceutical development and manufacturing, high-quality reference standards of the parent drug, along with its specific impurities, metabolites, and stable isotope labelled compounds, are critical for rigorous quality control. These reference materials are employed in analytical testing to ensure regulatory compliance and to support comprehensive impurity profiling. Laboratories utilize these compounds to conduct method validation, forced degradation studies, and the quantification of metabolic pathways. By providing stable isotope labelled standards and structural analogs, this collection assists in the precise identification of degradation products and the refinement of analytical methods during batch release and pharmaceutical research, ensuring the safety and consistency of the final drug product across various stages of development.